The increased neopterin content in turkish pediatric patients with sickle cell anemia
- 36 Downloads
In the present study, the possible activation of cellular immunity in SCD patients was investigated. As immune activation parameters, neopterin concentrations and kynurenine/tryptophan ratio for tryptophan degradation in 35 pediatric patients with sickle cell disease (31 HbSS and 4 HbSß) were determined. Our results have shown that neopterin levels (both urinary and serum) are increased in pediatric patients with sickle cell disease. The increase in neopterin concentration was accompanied by significantly increased biopterin, kynurenine concentration and kynurenine/tryptophan ratio. The mechanism of immune activation and the effects of inflammatory mediators in sickle cell disease are poorly understood, especially in terms of cell-mediated immunity. Further in-vivo and in-vitro studies are required to illuminate the association between neopterin levels and neutrophil activation in sickle cell disease.
KeywordsNeopterin Tryptophan Kynurenine Biopterin Sickle cell Anemia
Compliance with ethical standards
Conflict of interest
No conflict of interest was declared by the authors.
- 4.DeBaun MR, Galadanci NA (2019) Sickle cell disease in sub-Saharan Africa. Wolters Kluwer UpToDate. https://www.uptodate.com/contents/sickle-cell-disease-in-sub-saharan-africa/print
- 9.Pace BS, Ofori-Acquah SF, Peterson KR (2012) Sickle cell disease: genetics, cellular and molecular mechanisms, and therapies. Anemia 2012Google Scholar
- 15.Cunnington C, Channon KM (2010) Tetrahydrobiopterin: pleiotropic roles in cardiovascular pathophysiology. Heart:hrt. 2009:180430Google Scholar
- 17.Chen Y, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. International journal of tryptophan research 2:IJTR. S2097Google Scholar
- 30.Keikhaei B, Mohseni AR, Norouzirad R, Alinejadi M, Ghanbari S, Shiravi F, Solgi G (2013) Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition. Eur Cytokine Netw 24(1):45–52. https://doi.org/10.1684/ecn.2013.0328 CrossRefPubMedGoogle Scholar
- 35.Lanaro C, Franco-Penteado CF, Albuqueque DM, Saad ST, Conran N, Costa FF (2009) Altered levels of cytokines and inflammatory mediators in plasma and leukocytes of sickle cell anemia patients and effects of hydroxyurea therapy. J Leukoc Biol 85(2):235–242. https://doi.org/10.1189/jlb.0708445 CrossRefPubMedGoogle Scholar